Accessible Care: Microdosing offers a thoughtful, lower-intensity option for those seeking a monitored and guided protocol
Regulatory Oversight One of the most significant differences between compounded semaglutide and Wegovy is the level of regulatory oversight
GLP-1 is produced by specialised cells, known as L-cells, which are found predominantly in the lower part of the small intestine and the colon
Originally approved for people with type 2 diabetes, several GLP-1 receptor agonists now have FDA indications for weight management, including once-weekly injectable semaglutide 2.4 mg (Wegovy, Novo Nordisk) and tirzepatide (Zepbound, Eli Lilly), an injectable GIP/GLP-1 dual incretin-based agonist
Last month, Jelly Roll appeared on the cover of Mens Health , where he spoke candidly about the speculation surrounding GLP-1 medications
The four-year trial did not reveal any new safety concerns